1626 related articles for article (PubMed ID: 25731615)
1. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
2. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
[TBL] [Abstract][Full Text] [Related]
3. Characterization of astrocytes throughout life in wildtype and APP/PS1 mice after early-life stress exposure.
Abbink MR; Kotah JM; Hoeijmakers L; Mak A; Yvon-Durocher G; van der Gaag B; Lucassen PJ; Korosi A
J Neuroinflammation; 2020 Mar; 17(1):91. PubMed ID: 32197653
[TBL] [Abstract][Full Text] [Related]
4. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
[TBL] [Abstract][Full Text] [Related]
5. Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/- Vim-/- mice.
Widestrand A; Faijerson J; Wilhelmsson U; Smith PL; Li L; Sihlbom C; Eriksson PS; Pekny M
Stem Cells; 2007 Oct; 25(10):2619-27. PubMed ID: 17628017
[TBL] [Abstract][Full Text] [Related]
6. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
7. Protective role of reactive astrocytes in brain ischemia.
Li L; Lundkvist A; Andersson D; Wilhelmsson U; Nagai N; Pardo AC; Nodin C; Ståhlberg A; Aprico K; Larsson K; Yabe T; Moons L; Fotheringham A; Davies I; Carmeliet P; Schwartz JP; Pekna M; Kubista M; Blomstrand F; Maragakis N; Nilsson M; Pekny M
J Cereb Blood Flow Metab; 2008 Mar; 28(3):468-81. PubMed ID: 17726492
[TBL] [Abstract][Full Text] [Related]
8. AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
Yang J; Zhang R; Shi C; Mao C; Yang Z; Suo Z; Torp R; Xu Y
J Alzheimers Dis; 2017; 57(1):157-169. PubMed ID: 28222512
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
[TBL] [Abstract][Full Text] [Related]
10. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.
Nakazawa T; Takeda M; Lewis GP; Cho KS; Jiao J; Wilhelmsson U; Fisher SK; Pekny M; Chen DF; Miller JW
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2760-8. PubMed ID: 17525210
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease.
Kamphuis W; Middeldorp J; Kooijman L; Sluijs JA; Kooi EJ; Moeton M; Freriks M; Mizee MR; Hol EM
Neurobiol Aging; 2014 Mar; 35(3):492-510. PubMed ID: 24269023
[TBL] [Abstract][Full Text] [Related]
12. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model.
Kamphuis W; Orre M; Kooijman L; Dahmen M; Hol EM
Glia; 2012 Apr; 60(4):615-29. PubMed ID: 22262260
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
15. Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice.
Metaxas A; Vaitheeswaran R; Jensen KT; Thygesen C; Ilkjaer L; Darvesh S; Finsen B
Curr Alzheimer Res; 2018 Mar; 15(5):420-428. PubMed ID: 28982335
[TBL] [Abstract][Full Text] [Related]
16. Early Activation of Astrocytes does not Affect Amyloid Plaque Load in an Animal Model of Alzheimer's Disease.
Wang D; Zhang X; Wang M; Zhou D; Pan H; Shu Q; Sun B
Neurosci Bull; 2018 Dec; 34(6):912-920. PubMed ID: 30032411
[TBL] [Abstract][Full Text] [Related]
17. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice.
Kraft AW; Hu X; Yoon H; Yan P; Xiao Q; Wang Y; Gil SC; Brown J; Wilhelmsson U; Restivo JL; Cirrito JR; Holtzman DM; Kim J; Pekny M; Lee JM
FASEB J; 2013 Jan; 27(1):187-98. PubMed ID: 23038755
[TBL] [Abstract][Full Text] [Related]
18. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice.
Ribotta MG; Menet V; Privat A
Acta Neurochir Suppl; 2004; 89():87-92. PubMed ID: 15335106
[TBL] [Abstract][Full Text] [Related]
19. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
20. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
